EASTERN CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EASTERN CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $248.97M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $272.75M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $258.86M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $279.27M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $246.52M | Mar 14, 2023 |
| FY2013 | Dec 28, 2013 | $142.46M | Mar 12, 2014 |
| FY2013 | Dec 29, 2012 | $157.51M | Mar 12, 2014 |
| FY2013 | Dec 31, 2011 | $142.86M | Mar 12, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $248.97M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $272.75M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $258.86M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $279.27M | Mar 12, 2024 |
| FY2022 | Jan 1, 2022 | $246.52M | Mar 17, 2022 |
| FY2022 | Dec 31, 2021 | $246.52M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $197.61M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $251.74M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $234.28M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $204.24M | Mar 14, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $56.96M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $67.27M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $61.77M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $58.62M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $56.77M | Mar 17, 2022 |
| FY2022 | Jan 2, 2021 | $48.09M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $61.85M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $58.73M | Mar 5, 2020 |
| FY2017 | Dec 30, 2017 | $13.84M | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | $11.95M | Mar 15, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $7.13M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | ($8.53M) | Mar 19, 2026 |
| FY2023 | Dec 31, 2023 | $8.59M | Mar 12, 2024 |
| FY2024 | Dec 30, 2023 | $8.59M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $12.30M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $9.35M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $5.41M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $13.27M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $14.51M | Mar 5, 2020 |
| FY2017 | Dec 30, 2017 | ($168.8K) | Mar 15, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $10.67M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $20.15M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $17.03M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $14.17M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $17.45M | Mar 17, 2022 |
| FY2022 | Jan 2, 2021 | $13.51M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $17.46M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $17.86M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $12.08M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $11.14M | Mar 15, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $4.06M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $4.89M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $5.59M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $4.24M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $4.10M | Mar 17, 2022 |
| FY2022 | Jan 2, 2021 | $2.75M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $6.02M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $6.95M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $5.62M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $1.53M | Mar 15, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $42.22M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $42.23M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $39.15M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $39.51M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $35.22M | Mar 17, 2022 |
| FY2022 | Jan 2, 2021 | $30.19M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $35.72M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $33.91M | Mar 5, 2020 |
| FY2017 | Dec 30, 2017 | $8.40M | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | $6.53M | Mar 15, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $8.87M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $19.39M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $25.54M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $7.33M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | ($7.76M) | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $14.56M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $22.96M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $12.88M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $11.18M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $12.42M | Mar 15, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $3.97M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $9.71M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $5.54M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $3.37M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $3.72M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $2.34M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $5.44M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $3.60M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $2.76M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.86M | Mar 15, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $216.68M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $235.31M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $252.04M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $261.52M | Mar 12, 2024 |
| FY2022 | Jan 1, 2022 | $266.33M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $275.53M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $280.66M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $181.25M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $176.46M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $124.20M | Mar 15, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $92.03M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $114.62M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $119.56M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $134.91M | Mar 12, 2024 |
| FY2022 | Jan 1, 2022 | $151.73M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $171.22M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $175.23M | Mar 16, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $124.65M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $120.69M | Mar 19, 2026 |
| FY2023 | Dec 31, 2023 | $132.48M | Mar 12, 2024 |
| FY2026 | Dec 30, 2023 | $132.48M | Mar 19, 2026 |
| FY2024 | Dec 31, 2022 | $126.61M | Mar 11, 2025 |
| FY2022 | Jan 1, 2022 | $114.60M | Mar 14, 2023 |
| FY2023 | Dec 31, 2021 | $114.60M | Mar 12, 2024 |
| FY2022 | Jan 2, 2021 | $104.31M | Mar 14, 2023 |
| FY2022 | Dec 28, 2019 | $105.44M | Mar 17, 2022 |
| FY2020 | Dec 29, 2018 | $96.87M | Mar 16, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $58.63M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $58.51M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $58.58M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $70.78M | Mar 12, 2024 |
| FY2022 | Jan 1, 2022 | $72.21M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $72.22M | Mar 17, 2022 |
| FY2022 | Aug 10, 2020 | $2.30M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $79.52M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $34.84M | Mar 5, 2020 |
| FY2019 | Dec 30, 2017 | $32.23M | Mar 5, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $138.00M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $133.55M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $144.81M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $138.99M | Mar 12, 2024 |
| FY2022 | Jan 1, 2022 | $129.42M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | ($122.84M) | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $120.19M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $109.67M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $97.92M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $95.63M | Mar 15, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $7.41M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $14.01M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $8.05M | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | $10.19M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $6.17M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $15.32M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $18.00M | Mar 16, 2021 |
| FY2020 | Dec 29, 2018 | $13.93M | Mar 16, 2021 |
| FY2020 | Dec 27, 2018 | $13.93M | Mar 16, 2021 |
| FY2018 | Dec 30, 2017 | $22.28M | Mar 14, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | $33.90M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | $42.24M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | $43.94M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | $64.15M | Mar 12, 2024 |
| FY2022 | Jan 1, 2022 | $71.31M | Mar 17, 2022 |
| FY2022 | Dec 31, 2021 | $71.31M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $88.69M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | $98.77M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | $28.68M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $35.23M | Mar 14, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | 1 | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | (1) | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | 1 | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | 1 | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | 2 | Mar 17, 2022 |
| FY2022 | Jan 2, 2021 | 1 | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | 2 | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | 2 | Mar 5, 2020 |
| FY2017 | Dec 30, 2017 | 0 | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 15, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | 1 | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | (1) | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | 1 | Mar 11, 2025 |
| FY2022 | Dec 31, 2022 | 1 | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | 2 | Mar 17, 2022 |
| FY2022 | Jan 2, 2021 | 1 | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | 2 | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | 2 | Mar 5, 2020 |
| FY2017 | Dec 30, 2017 | 0 | Mar 15, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 15, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2026 | Jan 3, 2026 | 6.04M | Mar 19, 2026 |
| FY2026 | Dec 28, 2024 | 6.16M | Mar 19, 2026 |
| FY2024 | Dec 30, 2023 | 6.22M | Mar 11, 2025 |
| FY2023 | Dec 31, 2022 | 6.22M | Mar 12, 2024 |
| FY2022 | Jan 1, 2022 | 6.27M | Mar 17, 2022 |
| FY2022 | Dec 31, 2021 | 6.27M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | 6.25M | Mar 17, 2022 |
| FY2020 | Dec 28, 2019 | 6.24M | Mar 16, 2021 |
| FY2019 | Dec 29, 2018 | 6.23M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | 6.26M | Mar 14, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 30, 2023 | $2.77M | Mar 12, 2024 |
| FY2022 | Dec 31, 2022 | $2.74M | Mar 14, 2023 |
| FY2022 | Jan 1, 2022 | $2.76M | Mar 14, 2023 |
| FY2022 | Jan 2, 2021 | $2.75M | Mar 17, 2022 |
| FY2019 | Dec 28, 2019 | $2.74M | Mar 5, 2020 |
| FY2019 | Dec 29, 2018 | $2.76M | Mar 5, 2020 |
| FY2018 | Dec 30, 2017 | $2.75M | Mar 14, 2019 |
| FY2017 | Dec 31, 2016 | $2.75M | Mar 15, 2018 |
| FY2017 | Jan 2, 2016 | $2.81M | Mar 15, 2018 |
| FY2016 | Jan 3, 2015 | $2.99M | Mar 15, 2017 |